Asaren
Asa Rén is a precision medicine company leveraging AI and real-world evidence to advance personalized treatments, predict medicine performance, and discover life-saving technologies. Their ecosystem is powered by over 2 million genomic and medical records and supports Indonesia's National Genome Program with 280+ standardized data variables. They operate across individuals, healthcare providers, and life sciences, offering AI-driven digital health twin technology (AsaX) that integrates DNA insights with clinical and lifestyle data for personalized health management. They also provide real-world evidence access for pharma and health stakeholders to accelerate drug discovery and clinical research.
Asaren
Asa Rén is a precision medicine company leveraging AI and real-world evidence to advance personalized treatments, predict medicine performance, and discover life-saving technologies. Their ecosystem is powered by over 2 million genomic and medical records and supports Indonesia's National Genome Program with 280+ standardized data variables. They operate across individuals, healthcare providers, and life sciences, offering AI-driven digital health twin technology (AsaX) that integrates DNA insights with clinical and lifestyle data for personalized health management. They also provide real-world evidence access for pharma and health stakeholders to accelerate drug discovery and clinical research.